Literature DB >> 680791

Mechanisms of long and short term immunity to plague.

A Wake, H Morita, M Wake.   

Abstract

Long and short term immunity to plague was produced in normal mice by using, respectively, an antibiotic resistant Yersinia pestis and Yersinia pseudotuberculosis. Both immunogens were used live. Passive serum transfer experiments, together with assays for the bactericidal activity of macrophages and delayed hypersensitivity tests, showed that the short term immunity was of a humoral nature and the long term immunity was cell mediated. The plague virulence markers of the two immunogens were: Y. pestis VW- F1+ P1+ P+; Y. pseudotuberculosis VW+ F1- P1- P-. The challenge organism was Y. pestis VW+ F1+ P1+ P+.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 680791      PMCID： PMC1457423     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  13 in total

1.  BIOSYNTHESIS AND PURIFICATION OF V AND W ANTIGEN IN PASTEURELLA PESTIS.

Authors:  W D LAWTON; R L ERDMAN; M J SURGALLA
Journal:  J Immunol       Date:  1963-08       Impact factor: 5.422

2.  The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague.

Authors:  D C CAVANAUGH; R RANDALL
Journal:  J Immunol       Date:  1959-10       Impact factor: 5.422

3.  A slide microtechnique for the analysis of immune precipitates in gel.

Authors:  C WADSWORTH
Journal:  Int Arch Allergy Appl Immunol       Date:  1957

4.  The basis of virulence in Pasteurella pestis: an antigen determining virulence.

Authors:  G A BACON; T W BURROWS
Journal:  Br J Exp Pathol       Date:  1956-10

5.  The effect of an iron drug on the growth of plague microorganisms in vitro and in guinea pig skin.

Authors:  H Tsukano; M Yamamoto; A Wake
Journal:  Jpn J Med Sci Biol       Date:  1972-04

6.  The host response to Calmette-Guérin bacillus infection in mice.

Authors:  R V Blanden; M J Lefford; G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

7.  Tularaemia in the rat. I. The cellular basis on host resistance to infection.

Authors:  A A Kostiala; D D McGregor; P S Logie
Journal:  Immunology       Date:  1975-05       Impact factor: 7.397

8.  Recent studies on the immunity response to administration of different plague vaccines.

Authors:  K F MEYER
Journal:  Bull World Health Organ       Date:  1953       Impact factor: 9.408

9.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

10.  Mechanisms of acquired resistance in mouse typhoid.

Authors:  R V Blanden; G B Mackaness; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307
View more
  9 in total

1.  Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague.

Authors:  Wei Sun; Shilpa Sanapala; Hannah Rahav; Roy Curtiss
Journal:  Vaccine       Date:  2015-10-26       Impact factor: 3.641

2.  LcrV plague vaccine with altered immunomodulatory properties.

Authors:  Katie A Overheim; R William Depaolo; Kristin L Debord; Elizabeth M Morrin; Debra M Anderson; Nathaniel M Green; Robert R Brubaker; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.

Authors:  Lauriane E Quenee; Nancy A Ciletti; Derek Elli; Timothy M Hermanas; Olaf Schneewind
Journal:  Vaccine       Date:  2011-07-16       Impact factor: 3.641

4.  Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.

Authors:  Shixia Wang; Jon D Goguen; Fusheng Li; Shan Lu
Journal:  Vaccine       Date:  2011-01-01       Impact factor: 3.641

5.  Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen.

Authors:  A Roggenkamp; A M Geiger; L Leitritz; A Kessler; J Heesemann
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

6.  Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.

Authors:  Thierry Blisnick; Patrick Ave; Michel Huerre; Elisabeth Carniel; Christian E Demeure
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

7.  The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection.

Authors:  Nihal A Okan; Patricio Mena; Jorge L Benach; James B Bliska; A Wali Karzai
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441

8.  Delayed-type hypersensitivity and acquired resistance to plague in mice immunized with killed Yersinia pestis and immunoregulators.

Authors:  B Hurtrel; J M Alonso; P H Lagrange; M Hurtrel
Journal:  Immunology       Date:  1981-10       Impact factor: 7.397

9.  Immune responses to plague infection in wild Rattus rattus, in Madagascar: a role in foci persistence?

Authors:  Voahangy Andrianaivoarimanana; Sandra Telfer; Minoarisoa Rajerison; Michel A Ranjalahy; Fehivola Andriamiarimanana; Corinne Rahaingosoamamitiana; Lila Rahalison; Ronan Jambou
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.